UK-based pharmaceutical conglomerate GlaxoSmithKline (GSK) and UK-based automotive company the McLaren Group signed a strategic agreement yesterday, set to run initially until 2016.
GSK is looking to harness McLaren’s expertise in analytics and data modelling, which it will chiefly use in its nutritionals unit, as well as in manufacturing, consumer healthcare and research & development. McLaren had struck a similar partnership with the UK’s Civil Aviation Authority to handle large data needs in real time.
Andrew Witty, chief executive officer…
